116 related articles for article (PubMed ID: 37920080)
1. Expression of m6A Regulator Genes can Facilitate the Diagnosis of Chronic Heart Failure.
Zhou F; Yu Y; Li Y; Chen J; Wen S; Liu N; Li X; Bai R; Yan W
Heart Surg Forum; 2023 Oct; 26(5):E485-E497. PubMed ID: 37920080
[TBL] [Abstract][Full Text] [Related]
2. m6A regulator-mediated RNA methylation modification patterns are involved in the regulation of the immune microenvironment in ischaemic cardiomyopathy.
Zheng PF; Hong XQ; Liu ZY; Zheng ZF; Liu P; Chen LZ
Sci Rep; 2023 Apr; 13(1):5904. PubMed ID: 37041267
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma.
Yu Y; Liang C; Tang Q; Shi Y; Shen L
Gene; 2024 Feb; 894():147989. PubMed ID: 37972699
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.
Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S
BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis, clustering, and immune cell infiltration analysis of m6A-related genes in patients with acute myocardial infarction-a bioinformatics analysis.
Liang C; Wang S; Zhang M; Li T
J Thorac Dis; 2022 May; 14(5):1607-1619. PubMed ID: 35693610
[TBL] [Abstract][Full Text] [Related]
6. Significance of RNA N6-methyladenosine regulators in the diagnosis and subtype classification of coronary heart disease using the Gene Expression Omnibus database.
Jiang Y; Pan Y; Long T; Qi J; Liu J; Zhang M
Front Cardiovasc Med; 2023; 10():1185873. PubMed ID: 37928762
[TBL] [Abstract][Full Text] [Related]
7. Role of the N6-methyladenosine regulatory factor in reducing the risk of cardiovascular disease: subtype diagnosis following aerobic exercise-assisted weight loss.
Hao X; Li Y; Huang G; Zeng Y
Am J Transl Res; 2022; 14(8):5363-5378. PubMed ID: 36105062
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics identification and experimental validation of m6A-related diagnostic biomarkers in the subtype classification of blood monocytes from postmenopausal osteoporosis patients.
Zhang P; Chen H; Xie B; Zhao W; Shang Q; He J; Shen G; Yu X; Zhang Z; Zhu G; Chen G; Yu F; Liang D; Tang J; Cui J; Liu Z; Ren H; Jiang X
Front Endocrinol (Lausanne); 2023; 14():990078. PubMed ID: 36967763
[TBL] [Abstract][Full Text] [Related]
9. Significance of RNA N6-Methyladenosine Regulators in the Diagnosis and Subtype Classification of Childhood Asthma Using the Gene Expression Omnibus Database.
Dai B; Sun F; Cai X; Li C; Liu H; Shang Y
Front Genet; 2021; 12():634162. PubMed ID: 33763115
[TBL] [Abstract][Full Text] [Related]
10. Recognition of the Subtypes Classification and Diagnostic Signature Based on RNA N6-Methyladenosine Regulators in Recurrent Spontaneous Abortion.
Wang Z; Dai F; Liu H; Cheng Y
Reprod Sci; 2023 Dec; 30(12):3537-3547. PubMed ID: 37488406
[TBL] [Abstract][Full Text] [Related]
11. Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis.
Huang G; Huang S; Cui H
Front Pharmacol; 2022; 13():993567. PubMed ID: 36518679
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine regulators are potential prognostic biomarkers for multiple myeloma.
Wang J; Zuo Y; Lv C; Zhou M; Wan Y
IUBMB Life; 2023 Feb; 75(2):137-148. PubMed ID: 36177774
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS).
Zhou S; Hua R; Quan S
J Ovarian Res; 2023 Apr; 16(1):73. PubMed ID: 37046273
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators in the Diagnosis and Subtype Classification of Acute Myocardial Infarction.
Wang X; Wu Y; Guo R; Zhao L; Yan J; Gao C
J Immunol Res; 2022; 2022():5173761. PubMed ID: 36061306
[TBL] [Abstract][Full Text] [Related]
15. Identification of RNA N6-methyladenosine regulation in epilepsy: Significance of the cell death mode, glycometabolism, and drug reactivity.
Liu X; Sun Q; Cao Z; Liu W; Zhang H; Xue Z; Zhao J; Feng Y; Zhao F; Wang J; Wang X
Front Genet; 2022; 13():1042543. PubMed ID: 36468034
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of N6-Methyladenosine RNA Methylation Regulators Expression Identify Distinct Molecular Subtypes of Myocardial Infarction.
Shi X; Cao Y; Zhang X; Gu C; Liang F; Xue J; Ni HW; Wang Z; Li Y; Wang X; Cai Z; Hocher B; Shen LH; He B
Front Cell Dev Biol; 2021; 9():756483. PubMed ID: 34778266
[No Abstract] [Full Text] [Related]
17. m6A regulator-mediated methylation modification patterns and immune microenvironment infiltration characterization in osteoarthritis.
Hu S; Shen C; Yao X; Zou Y; Wang T; Sun X; Nie M
BMC Med Genomics; 2022 Dec; 15(1):273. PubMed ID: 36585683
[TBL] [Abstract][Full Text] [Related]
18. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis.
Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L
Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449
[TBL] [Abstract][Full Text] [Related]
20. Gene signature of m6A-related targets to predict prognosis and immunotherapy response in ovarian cancer.
Tan W; Liu S; Deng Z; Dai F; Yuan M; Hu W; Li B; Cheng Y
J Cancer Res Clin Oncol; 2023 Feb; 149(2):593-608. PubMed ID: 36048273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
